Loading
David Dean Halbert received $20.4M in total compensation as Chief Executive Officer of Caris Life Sciences, Inc. in FY2025. The largest component was $15.4M in stock awards. Source: SEC DEF 14A.
In fiscal year 2025, David Dean Halbert, Chief Executive Officer of Caris Life Sciences, Inc. (CAI), received total compensation of $20.4 million.
David Dean Halbert's compensation breakdown includes: base salary of $765K, bonus of $3.3 million, stock awards valued at $15.4 million, and other compensation of $926K.
Caris Life Sciences, Inc.'s top 3 named executive officers received combined total compensation of $37.3 million in fiscal year 2025.
The named executive officers disclosed in Caris Life Sciences, Inc.'s 2025 proxy statement are:David Dean Halbert (Chief Executive Officer) with total compensation of $20.4 million, David Spetzler (President) with total compensation of $11.6 million, and J. Russel Denton (Senior Vice President General Counsel and Secretary) with total compensation of $5.4 million.
David Dean Halbert, Chief Executive Officer of Caris Life Sciences, Inc. (CAI), received $20,350,571 in total compensation for FY2025. Stock awards of $15,400,569 were the largest component. Figures come from Caris Life Sciences, Inc.'s DEF 14A 0002019410-26-000032 filed 23 Apr 2026.
Source Filing
Executive Record
David Dean Halbert
Chief Executive Officer
Reported Pay
$20.4MSummary compensation table total · FY2025
Findings
Reviewing FY2025 compensation of $20.4M against shareholder return and the latest filing-backed pay disclosures.
Spread between reported pay and stock performance is pending computation.
Evidence is sourced from the latest executive compensation filing and return series for CAI.
Caris Life Sciences, Inc. (CAI) — Key Facts
Last updated May 1, 2026 · DEF 14A filed Apr 23, 2026
| CEO | David Dean Halbert, Chief Executive Officer |
|---|---|
| Fiscal year | FY2025 |
| Total compensation | $20.4M |
| Base salary | $765K |
| Stock awards | $15.4M |
| Other compensation | $926K |
| Source | DEF 14A, 2026-04-23 |
David Dean Halbert, the Chief Executive Officer of Caris Life Sciences, Inc., received total compensation of $20,350,571 in fiscal year 2025. This includes base salary of $764,918 and stock awards valued at $15,400,569. Figures come from Caris Life Sciences, Inc.'s DEF 14A 0002019410-26-000032 filed 23 Apr 2026.
David Dean Halbert's base salary at Caris Life Sciences, Inc. is $764,918 per year as of fiscal year 2025. However, total compensation including stock awards, bonuses, and other benefits is $20,350,571. Figures come from Caris Life Sciences, Inc.'s DEF 14A 0002019410-26-000032 filed 23 Apr 2026.
Caris Life Sciences, Inc.'s CEO, David Dean Halbert, earned $20,350,571 in total compensation for fiscal year 2025. The majority of this compensation comes from stock awards ($15,400,569) rather than base salary ($764,918). Figures come from Caris Life Sciences, Inc.'s DEF 14A 0002019410-26-000032 filed 23 Apr 2026.
Reading filings for CAI...
Reading the latest proxy statement
Calculating CEO-to-worker ratio
Checking insider sales and trading plans